Adirondack Trust Company’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394 | Hold |
150
| – | – | ﹤0.01% | 472 |
|
|
2025
Q1 | $450 | Hold |
150
| – | – | ﹤0.01% | 468 |
|
|
2024
Q4 | $382 | Hold |
150
| – | – | ﹤0.01% | 476 |
|
|
2024
Q3 | $558 | Sell |
150
-300
| -67% | -$1.12K | ﹤0.01% | 478 |
|
|
2024
Q2 | $2.84K | Hold |
450
| – | – | ﹤0.01% | 440 |
|
|
2024
Q1 | $2.42K | Hold |
450
| – | – | ﹤0.01% | 459 |
|
|
2023
Q4 | $2.13K | Hold |
450
| – | – | ﹤0.01% | 461 |
|
|
2023
Q3 | $760 | Hold |
450
| – | – | ﹤0.01% | 474 |
|
|
2023
Q2 | $990 | Hold |
450
| – | – | ﹤0.01% | 450 |
|
|
2023
Q1 | $814 | Hold |
450
| – | – | ﹤0.01% | 472 |
|
|
2022
Q4 | $2.28K | Hold |
450
| – | – | ﹤0.01% | 439 |
|
|
2022
Q3 | $2K | Buy |
450
+150
| +50% | +$667 | ﹤0.01% | 443 |
|
|
2022
Q2 | $1K | Buy |
+300
| New | +$1K | ﹤0.01% | 441 |
|